EFFICACY AND SAFETY OF SUCROFERRIC OXYHYDROXIDE VS SEVELAMER CARBONATE IN CHINESE DIALYSIS PATIENTS WITH HYPERPHOSPHATAEMIA

WCN23-0681
AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
 
Acid-base and Electrolyte Abnormalities in Kidney Disease
 
 
 
EFFICACY AND SAFETY OF SUCROFERRIC OXYHYDROXIDE VS SEVELAMER CARBONATE IN CHINESE DIALYSIS PATIENTS WITH HYPERPHOSPHATAEMIA
Liu, J.(1);Zuo, L.(2);Walpen, S.(3);Bernard, L.(4);Marty, M.(5);Enoiu, M.(5)*;
ie: Azwin Z.1, Siti Y.1, John D.2
(1)Nanfang Hospital Of Southern Medical University, Department Of Nephrology, Guangzhou City, China;(2)Peking University People’S Hospital, Department Of Nephrology, Beijing, China;(3)Vifor Pharma Management Ltd., Medical Information, Glattbrugg, Switzerland;(4)Vifor Pharma Management Ltd., Clinical Development, Glattbrugg, Switzerland;(5)Vifor Pharma Management Ltd., Clinical Research, Glattbrugg, Switzerland;
https://storage.unitedwebnetwork.com/files/1041/4d77396c3745351bd51b952bf0a3e7d6.pdf
https://storage.unitedwebnetwork.com/files/1041/5fec2de36c7ef52c61c5ac62c3ddeb61.mp3
if any